Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

WILLIAM AUGUSTUS BYRD

Allopathic & Osteopathic Physicians Ophthalmology

NPI
1316937998
CMS profile
941802
Location
SHREVEPORT, LA

General Payments · PY2018–2024

$3,466.13

  • Reported across 65 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$856.07

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $856.07 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $219.96 6
Alcon Laboratories Inc $218.63 2
Amgen Inc. $192.23 4
Dompe US, Inc. $133.33 1
Sight Sciences, Inc. $67.95 1
Bausch & Lomb Americas Inc. $23.97 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $274.38 6
PY2019 $386.84 4
PY2020 $58.52 3
PY2021 $559.49 9
PY2022 $460.60 10
PY2023 $870.23 18
PY2024 $856.07 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $19.67 04/11/2024 Food and Beverage Undisputed 01/23/2026 1103400765 CMS
ABBVIE INC. $14.84 06/19/2024 Food and Beverage Undisputed 01/23/2026 1103400767 CMS
ABBVIE INC. $117.65 07/18/2024 Food and Beverage Undisputed 01/23/2026 1103400769 CMS
ABBVIE INC. $20.85 10/03/2024 Food and Beverage Undisputed 01/23/2026 1103400771 CMS
ABBVIE INC. $22.63 11/25/2024 Food and Beverage Undisputed 01/23/2026 1103400773 CMS
ABBVIE INC. $24.32 12/05/2024 Food and Beverage Undisputed 01/23/2026 1103400775 CMS
Alcon Vision LLC $150.00 03/21/2024 Food and Beverage Undisputed 01/23/2026 1110565595 CMS
Alcon Vision LLC $68.63 08/16/2024 Food and Beverage Undisputed 01/23/2026 1110565593 CMS
Amgen Inc. $12.54 01/30/2024 Food and Beverage Undisputed 01/23/2026 1115474571 CMS
Amgen Inc. $21.86 02/06/2024 Food and Beverage Undisputed 01/23/2026 1115474564 CMS
Amgen Inc. $32.83 02/21/2024 Food and Beverage Undisputed 01/23/2026 1115474578 CMS
Amgen Inc. $125.00 02/21/2024 Food and Beverage Undisputed 01/23/2026 1115474584 CMS
Bausch & Lomb Americas Inc. $23.97 09/04/2024 Food and Beverage Undisputed 01/23/2026 1140466997 CMS
Dompe US, Inc. $133.33 01/25/2024 Food and Beverage Undisputed 01/23/2026 1151418311 CMS
Sight Sciences, Inc. $67.95 02/15/2024 Food and Beverage Undisputed 01/23/2026 1151931813 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.